Health

Results: 229-240 of 8082

Pulselight platform now available to NHS via £10bn Fortrus Framework

Almirall’s 2025 Results

Plastic Surgeons Call for Ban on Breast Fillers Over Cancer and Safety Fears

Prothena Reports Fourth Quarter and Full Year 2025 Financial Results, and Provides Financial Guidance and Business Highlights

Positive Phase 3 Data Demonstrate Potential for ENTYVIO® (vedolizumab) to Address Treatment Gap for Children and Adolescents with Moderate to Severe Ulcerative Colitis

SciBase's Nevisense (EIS) Included in the US NCCN Guidelines for Melanoma which supports the use of EIS in the detection of melanoma

3Shape Boosts Dental Lab Speed and Accuracy with AI-Powered Workflows

PR Newswire associated0

Cambrex Announces Cornell Professor Song Lin as Recipient of the 2025 Snapdragon Prize for Innovation in Chemistry Technology

YolTech Therapeutics Announces Positive Interim Data on YOLT-202 for the Treatment of Alpha-1 Antitrypsin Deficiency

North West London NHS trusts unify imaging with Sectra's cloud platform to boost collaboration and speed diagnoses

Brenus Pharma Presented New Preclinical and Early Clinical Data in Colorectal Cancer During AACR Immuno-Oncology Conference 2026

ENHERTU® Type II Variation Application Validated in the EU as Post-Neoadjuvant Treatment for Patients with HER2 Positive Early Breast Cancer